Working groups
Dr Paula Ellenberg is a mid-career researcher with 12 years of post-doctoral experience in the field of Retrovirus pathogenesis. After being awarded her PhD in 2008 by the University of Buenos Aires for her studies on the Arenavirus Junin, she moved to Australia to join several multidisciplinary teams focused on Retrovirus biology with the primary goal of unmasking potential drug targets to eliminate HIV-1 and HTLV-1. Her studies resulted in 18 peer-reviewed publications in the virology space.
Dr Ellenberg is skilled in viral molecular cloning, including the introduction of genetic tags and mutations into the retroviral genome. Further, she has extensive experience in experimental design and implementation of retrovirus infection of primary cells.
Molecules
Adam Johnson, Catherine F. Latham, George W. Mbogo, Paula Ellenberg, David Tyssen, Gilda Tachedjian
AIDS Research and Human Retroviruses
Jacqueline K. Flynn, Paula Ellenberg, Renee C. Duncan, Anne Ellett, Jingling Zhou, Jasminka Sterjovski, Kieran Cashin, Katharina Borm, Lachlan Gray, Melissa J. Churchill
Retrovirology
Katharina Borm, Jacqueline K. Flynn, Paula Ellenberg, Melissa J. Churchill, Michael Roche
We’ve discovered Hervey pteropid gammaretrovirus, the first replication competent retrovirus circulating in Australian fruit bats, suggesting that bats can deal with multiple viral threats.
The vaginal microbiome is a key determinant of a women’s sexual and reproductive health. There is an unmet need for effective non-antibiotic-based strategies to target bacterial vaginosis and its adverse sequelae.
Projects are available to determine the direct anti-HIV and bactericidal mechanisms of vaginal microbiota metabolites.